The role of complement in disorders of the nervous system (Q41707700)

7 October 2017

1 reference

title

The role of complement in disorders of the nervous system (English)

1 reference

7 October 2017

Morgan BP

1

1 reference

7 October 2017

Gasque P

series ordinal

2

1 reference

7 October 2017

Singhrao S

series ordinal

3

1 reference

7 October 2017

Piddlesden SJ

series ordinal

4

1 reference

7 October 2017

1 December 1997

1 reference

7 October 2017

1 reference

7 October 2017

38

1 reference

7 October 2017

1-2

1 reference

7 October 2017

43-50

1 reference

The membrane attack complex of complement mediates peripheral nervous system demyelination in vitro.

7 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

Immunocytochemical localization of the terminal complement complex in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

Appearance of immunoglobulin G and complement factor C3 in the striatum after transient focal ischemia in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

Circulating immune complexes in multiple sclerosis: relation with disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

Amyloid deposition as the central event in the aetiology of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

Guillain-Barré syndrome: activated complement components C3a and C5a in CSF

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

Immune reactive C3d on the surface of myelin sheaths in neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

Characterization of complement-fixing antibodies to peripheral nerve myelin in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

Clinical correlation with anti-peripheral-nerve myelin antibodies in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

Effect of soluble complement receptor-1 on neutrophil accumulation after traumatic brain injury in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

Complement factors in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

The role of complement in the pathogenesis of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

Activation of the classical complement pathway in brain tissue of Alzheimer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

Complement proteins and complement inhibitors in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

Intrathecal complement activation in neurological diseases evaluated by analysis of the terminal complement complex

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

Complement-mediated demyelination in patients with IgM monoclonal gammopathy and polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

Experimental induction of myelin changes by anti-MAG antibodies and terminal complement complex

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

Expression of complement in the brain: role in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

Membrane proteins that protect against complement lysis

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

Guillain-Barré syndrome: demonstration of antibodies to peripheral nerve tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

Immune complexes and complement activation following rupture of intracranial saccular aneurysms

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

Killing of rat glial cells by complement: deficiency of the rat analogue of CD59 is the cause of oligodendrocyte susceptibility to lysis

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

Soluble complement receptor 1 (sCR1) protects against experimental autoimmune myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

Complement activation and beta-amyloid-mediated neurotoxicity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

Antibrain antibodies in multiple sclerosis. Relation to clinical variables.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

Role of complement in the aetiology of Pick's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

Complement activation in amyloid plaques in Alzheimer's disease brains does not proceed further than C3.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

Aspartate residue 7 in amyloid beta-protein is critical for classical complement pathway activation: implications for Alzheimer's disease pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

Measurement of complement components in cerebral spinal fluid by radioimmunoassay in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

Expression of the complement membrane attack complex and its inhibitors in Pick disease brain

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900059-3

7 January 2021

10.1016/S0162-3109(97)00059-3

Identifiers

DOI

1 reference

7 October 2017

1 reference